» Authors » Thomas Haupl

Thomas Haupl

Explore the profile of Thomas Haupl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 91
Citations 2574
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Palmowski A, Strehl C, Pfeiffenberger M, Haupl T, Schad M, Kallarackal J, et al.
Clin Rheumatol . 2023 Nov; 43(1):511-519. PMID: 37978145
Objectives: To identify biomarkers at the gene expression level to predict response to methotrexate (MTX) in patients with rheumatoid arthritis (RA). Methods: MTX-naïve patients with RA were started on MTX...
2.
Haupl T, Sorensen T, Smiljanovic B, Darcy M, Scheder-Bieschin J, Steckhan N, et al.
J Clin Med . 2023 Jul; 12(13). PMID: 37445394
Rheumatoid arthritis (RA) synovitis is dominated by monocytes/macrophages with inflammatory patterns resembling microbial stimulation. In search of triggers, we reduced the intestinal microbiome in 20 RA patients (open label study...
3.
Hartmann A, DellOro M, Spoo M, Fischer J, Steckhan N, Jeitler M, et al.
Front Nutr . 2022 Nov; 9:1030380. PMID: 36407522
Background: Fasting is beneficial in many diseases, including rheumatoid arthritis (RA), with lasting effects for up to 1 year. However, existing data dates back several decades before the introduction of...
4.
Marklein B, Jenning M, Konthur Z, Haupl T, Welzel F, Nonhoff U, et al.
Arthritis Res Ther . 2021 Oct; 23(1):255. PMID: 34627334
No abstract available.
5.
Karow F, Smiljanovic B, Grun J, Poddubnyy D, Proft F, Talpin A, et al.
Arthritis Res Ther . 2021 Sep; 23(1):246. PMID: 34560894
Background: In patients with axial spondyloarthritis (axSpA), monocytes show a pre-activated phenotype. Gut inflammation is a trigger of monocyte activation and may also affect their development in the bone marrow...
6.
Marklein B, Jenning M, Konthur Z, Haupl T, Welzel F, Nonhoff U, et al.
Arthritis Res Ther . 2021 Sep; 23(1):239. PMID: 34521462
Background: There is a need for biomarker to identify patients "at risk" for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the...
7.
Hartmann A, DellOro M, Kessler C, Schumann D, Steckhan N, Jeitler M, et al.
BMJ Open . 2021 Aug; 11(8):e047758. PMID: 34380725
Background: Previous studies have shown beneficial effects of therapeutic fasting and plant-based dietary interventions on disease activity in patients with rheumatoid arthritis (RA) for a duration of up to 1 ...
8.
Seifert G, Jeitler M, Stange R, Michalsen A, Cramer H, Brinkhaus B, et al.
Front Med (Lausanne) . 2020 Dec; 7:587749. PMID: 33363186
During the COVID-19 pandemic people are facing risks of adverse health effects due to the restrictions implemented such as quarantine measures, reduced social contact, and self-isolation. In this qualitative review,...
9.
Liebold I, Grutzkau A, Gockeritz A, Gerl V, Lindquist R, Feist E, et al.
Rheumatology (Oxford) . 2020 Nov; 60(4):1984-1995. PMID: 33200208
Objective: Epigenetic modifications are dynamic and influence cellular disease activity. The aim of this study was to investigate global DNA methylation in peripheral blood mononuclear cells (PBMCs) of RA patients...
10.
Ghannam K, Martinez Gamboa L, Kedor C, Spengler L, Kuckelkorn U, Haupl T, et al.
RMD Open . 2020 Oct; 6(3). PMID: 32998980
Objective: Abatacept is a biological disease-modifying antirheumatic drug (DMARD) used for the treatment of rheumatoid arthritis (RA) and modulates the costimulatory signal by cluster of differentiation (CD)28:CD80/CD86 interaction required for...